Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

The dual function of eosinophils is clearly illustred in schistosomiasis. Well equipped in membrane receptors for immunoglobulins and complement, and due to the presence of granule basic proteins, ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in blood and tissues, with multisystem involvement. Cardiac manifestations are ...

Researchers at the Hebrew University of Jerusalem said Monday that they have identified a previously unknown immune defense that helps the body control dangerous Candida infections. Working in ...

This post shows how to change what the Fn keys do in Windows 11/10. The Fn or the Function key is a meta-modifier key used to activate secondary functions or special features on certain keys. The ...

Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly reduce ...

When you have asthma, the airways in your lungs get narrow and swollen. They also make too much mucus. This sets off spasms in the tubes that let air in and out of your lungs (bronchial tubes). The ...

UC Riverside scientists delve into the immune intricacies of obesity and parasitic infections, examining how gender-specific responses might unlock new treatments. Their work could reshape our ...

RIVERSIDE, Calif. -- Biomedical scientists at the University of California, Riverside have received a $3.7 million grant from the National Institutes of Health to study the role of sex-specific immune ...

Biomedical scientists at the University of California, Riverside have received a $3.7 million grant from the National Institutes of Health to study the role of sex-specific immune responses in obesity ...